TABLE 3.
ADMET parameter prediction of azithromycin and its related impurities in this study.
| Principal descriptor | Azithromycin | Impurity J | Impurity E | Impurity F | Impurity K | Impurity H | Impurity I | Impurity L | Impurity Q | Impurity R | Impurity S |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TPSA (Å2) | 180.09 | 152.39 | 202.88 | 197.16 | 189.32 | 243.33 | 188.88 | 193.92 | 178.22 | 178.22 | 209.44 |
| Log P a | 1.9007 | 0.9755 | 1.2978 | 1.4273 | 1.2387 | 2.6182 | 1.5585 | 1.9133 | 2.4053 | 2.4053 | 2.0467 |
| Absorption | |||||||||||
| Water solubility (log mol/L) | −4.133 | −3.918 | −4.073 | −4.069 | −4.049 | −3.246 | −4.104 | −4.331 | −4.621 | −4.588 | −4.164 |
| Caco2 permeability (log Papp in 10−6 cm/s) b | −0.211 | −0.122 | −0.228 | 0.154 | −0.074 | 0.289 | −0.227 | 0.29 | −0.012 | −0.055 | −0.149 |
| Distribution | |||||||||||
| VDss (human, log L/kg) | −0.214 | −0.09 | −0.293 | −0.43 | 0.245 | 0.065 | −0.243 | −0.514 | −0.25 | −0.151 | −0.238 |
| BBB permeability (logBB) | −1.857 | −1.263 | −1.772 | −1.959 | −1.847 | −2.409 | −1.856 | −2.018 | −1.677 | −1.681 | −1.882 |
| Metabolism | |||||||||||
| CYP2D6 substrate | No | No | No | No | No | No | No | No | No | No | No |
| CYP3A4 substrate | Yes | No | No | Yes | No | Yes | Yes | Yes | Yes | No | No |
| Excretion | |||||||||||
| Total clearance [log (ml/min/kg)] c | −0.424 | −0.472 | −0.349 | −0.271 | −0.53 | −0.824 | −0.292 | −0.426 | −0.219 | −0.133 | −0.661 |
| Toxicity | |||||||||||
| Hepatotoxicity | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Octanol/water partition coefficient.
Logarithm of the apparent permeability coefficient.
Drug clearance is measured by the proportionality constant CLtot.